Literature DB >> 19144370

Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells.

Masaya Takemoto1, Takayoshi Imasawa, Koichi Yamanishi, Yasuko Mori.   

Abstract

Human herpesvirus 6 (HHV-6) is a ubiquitous betaherpesvirus that predominantly infects and replicates in CD4(+) T lymphocytes. However, the mechanism of HHV-6 transmission to T cells from the peripheral mucosa is unknown. Here we found that dendritic cells (DCs) can transmit HHV-6 to T cells, resulting in productive infection. In immature monocyte-derived DCs (MDDCs) infected with HHV-6, viral early and late antigens were expressed, and nucleocapsids containing a DNA core were observed, although few virions were detected in the cytoplasm by electron microscopy, indicating that the maturation of HHV-6 virions may be incomplete in MDDCs. However, HHV-6 transmission from MDDCs to stimulated CD4(+) T cells occurred efficiently in coculture of these cells, but not from MDDCs culture supernatants. This transmission was partially inhibited by treating the DCs with a viral DNA synthesis blocker, indicating that viral replication in MDDCs is required for this transmission. Furthermore, myeloid DCs and plasmacytoid DCs infected with HHV-6 could also transmit the virus to stimulated T cells. Thus, DCs may be the first cell population targeted by HHV-6 and could play an important role in the virus' transmission to T cells for their further propagation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144370     DOI: 10.1016/j.virol.2008.11.049

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Human herpesvirus 6 infection impairs Toll-like receptor signaling.

Authors:  Yuichi Murakami; Kazushi Tanimoto; Hiroshi Fujiwara; Jun An; Koichiro Suemori; Toshiki Ochi; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Virol J       Date:  2010-05-10       Impact factor: 4.099

3.  Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.

Authors:  Fang Wang; Jing Chi; Guangyong Peng; Feng Zhou; Jinfeng Wang; Lingyun Li; Dongju Feng; Fangyi Xie; Bin Gu; Jian Qin; Yun Chen; Kun Yao
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

5.  Plasmacytoid dendritic cells and the control of herpesvirus infections.

Authors:  Thomas Baranek; Nicolas Zucchini; Marc Dalod
Journal:  Viruses       Date:  2009-10-14       Impact factor: 5.048

Review 6.  Viral ancestors of antiviral systems.

Authors:  Luis P Villarreal
Journal:  Viruses       Date:  2011-10-20       Impact factor: 5.048

Review 7.  Modulatory effects on dendritic cells by human herpesvirus 6.

Authors:  Rasmus Gustafsson; Mattias Svensson; Anna Fogdell-Hahn
Journal:  Front Microbiol       Date:  2015-04-30       Impact factor: 5.640

Review 8.  Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis.

Authors:  Wangko Lundström; Rasmus Gustafsson
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

9.  Human herpesvirus 6A partially suppresses functional properties of DC without viral replication.

Authors:  Rasmus K L Gustafsson; Elin E Engdahl; Oscar Hammarfjord; Sanjaya B Adikari; Magda Lourda; Jonas Klingström; Mattias Svensson; Anna Fogdell-Hahn
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Implication of human herpesviruses in oncogenesis through immune evasion and supression.

Authors:  Kenneth Alibek; Yeldar Baiken; Ainur Kakpenova; Assel Mussabekova; Samal Zhussupbekova; Madina Akan; Bolat Sultankulov
Journal:  Infect Agent Cancer       Date:  2014-01-20       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.